The Effectiveness of Chitosan and Snail Seromucous as Anti Tuberculosis Drugs

Agnes Sri Harti; Yusup Sutanto; Rahajeng Putriningrum; Tresia Umarianti; Erlina Windyastuti; Mellia Silvy Irdianty

doi:10.3889/oamjms.2021.6466

Authors

Agnes Sri Harti Departement of Nursing, Kusuma Husada University Surakarta, Surakarta, Indonesia
Yusup Sutanto Pulmonary Disease Study Program, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
Rahajeng Putriningrum Midwife Professional Study Program, Faculty of Health Sciences, Kusuma Husada University Surakarta, Surakarta, Indonesia
Tresia Umarianti Midwife Professional Study Program, Faculty of Health Sciences, Kusuma Husada University Surakarta, Surakarta, Indonesia
Erlina Windyastuti Departement of Nursing, Kusuma Husada University Surakarta, Surakarta, Indonesia
Mellia Silvy Irdianty Departement of Nursing, Kusuma Husada University Surakarta, Surakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.6466

Keywords:

Chitosan, Snail seromucous, Anti tubeculosis drug

Abstract

BACKGROUND: Tuberculosis (TB) disease is an infection caused by Mycobacterium tuberculosis (MTB) and is transmitted through sputum droplets of sufferers or suspect TB in the air. Chitosan has been widely used in the biomedical and pharmaceutical fields because it is a biocompatible, biodegradable, non-toxic, antimicrobial, and hydrating agent with positive effects on wound healing. Seromucous of snail has anti-tumor bioactivity and is non-toxic to lymphocyte cells, and can even stimulate lymphocyte proliferation. Seromucous of snail as glycoprotein containing carbohydrates; α-1 globulin-oromucoid fraction; glycans, peptides, glycopeptides, and chondroitin sulfate.

AIM: This study was to determine the effectiveness of snail seromucous and chitosan as anti TB drugs (ATD) in vitro.

METHODS: The research method is based on an experimental laboratory. MTB isolates in this research from sputum samples of patients suspected of TB in Surakarta Regional General Hospital. The stages of the study were performed MTB culture and identification, management sampling, and drug susceptibility testing.

RESULTS: The research results showed chitosan 5%; a combination of chitosan 9% and snail seromucous 50% (ratio 1:1) is a microbicide against MTB TB patient isolates. Snail seromucous was ineffective as a microbicide against MTB TB patients.

CONCLUSION: The effectiveness as a bactericide against MTB, chitosan, and its combination with snail seromucous has the potential to be an ATD alternative.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Ibrahim K, El-Eswed B, Abu-Sbeih K, Arafat T, Omari MA, Darras F, et al. Preparation of chito-oligomers by hydrolysis of chitosan in the presence of zeolite as adsorbent. Mar Drugs. 2016;14(8):43. https://doi.org/10.3390/md14080043 PMid:27455287 DOI: https://doi.org/10.3390/md14080043

Zhuang J, Coates C, Zhu H, Zhu P, Wu Z, Xie L, et al. Identification of candidate antimicrobial peptides derived from abalone hemocyanin. Immunol Dev Comp. 2015;49(1):96-102. https://doi.org/10.1016/j.dci.2014.11.008 PMid:25445903 DOI: https://doi.org/10.1016/j.dci.2014.11.008

Dang V, Benkendorff K, Green T, Speck P. Marine snails and slugs: A great place to look for antiviral drugs. J Virol. 2015;89(16):8114-8. https://doi.org/10.1128/jvi.00287-15 PMid:26063420 DOI: https://doi.org/10.1128/JVI.00287-15

Dolashka P, Dolashki A, Voelter W, Beeumen JV, Stevanovic S. Antimicrobial activity of peptides the hemolymph of Helix lucorum snails. Int J Curr Microbiol App Sci. 2015;4(4):1061-71. https://doi.org/10.2174/1389201016666150907113435

Harti A, Sulisetyawati S, Murharyati A, Oktariani M, Wijayanti I. The effectiveness of snail slime and chitosan in wound healing. Int J Pharm Med Biol Sci. 2016;5(1):76-80.

National Guidelines for Controlling Tuberculosis. Ministry of Health Republic of Indonesia. Jakarta: National Guidelines for Controlling Tuberculosis; 2014.

Ministry of Health Republic of Indonesia. Health Ministry of the Republic of Indonesia. Tuberculosis. Indonesia: Ministry of Health Republic of Indonesia; 2018. https://doi.org/10.18311/jeoh/2020/26134 DOI: https://doi.org/10.18311/jeoh/2020/26134

Octaviana U, Maryati A, Fatimah S, Harti A. Chitosan Biomembrane as Sanitary Pads. Final Report of the Creativity Students Program; 2015.

Harti A, Kusumawati H, Siswiyanti S, Setyaningtyas A. In vitro synergistics effects of snail slime and chitosan against Staphylococcus aureus. Int J Pharm Med Biol Sci. 2016;5(2):137-41.

Etim L, Aleruchi C, Obande G. Antibacterial properties of snail mucus on bacteria isolated from patients with wound infection. Br Microbiol Res J. 2016;11(2):1-9. https://doi.org/10.9734/bmrj/2016/21731 DOI: https://doi.org/10.9734/BMRJ/2016/21731

Harti A, Puspawati N, Putriningrum R. Antimicrobial bioactive compounds of snail seromucous as biological response modifier immunostimulator. Indones Microbiol 2019;13(3):56-63. https://doi.org/10.5454/mi.13.2.3 DOI: https://doi.org/10.5454/mi.13.2.3

Ulagesan S, Kim H. Antibacterial and antifungal activities of proteins extracted from seven different snails. Appl Sci. 2018;8(8):1362. https://doi.org/10.3390/app8081362 DOI: https://doi.org/10.3390/app8081362

Anggraini D, Darmawati S, Endang T. Protein Profile and Anti-microbial Power of Snail Slime (Achantina fulica) against Methicillin Resistant Staphylococcus aureus (MRSA). Student National Seminar 1: of Universitas Muhammadiyah Semarang; 2018. p. 73-7.

Nantarat N, Tragoolpua Y, Gunama P. Antibacterial activity of the mucus extract from the giant African Snail (Lissachatina fulica) and golden apple snail (Pomacea canaliculata) Against Pathogenic Bacteria Causing Skin Diseases. Trop Nat Hist Chulalongkorn Univ. 2019;19(2):103-12. https://doi.org/10.36468/pharmaceutical-sciences.673 DOI: https://doi.org/10.36468/pharmaceutical-sciences.673

Dolashka P, Dolashki A, Beeumen JV, Floetenmeyer M, Velkova L, Stevanovic S, et al. Antimicrobial activity of molluscan hemocyanins from helix and rapana snails. Curr Pharm Biotechnol. 2016;17(3):263-70. https://doi.org/10.2174/1389201016666150907113435 PMid:26343131 DOI: https://doi.org/10.2174/1389201016666150907113435

Harti A, Murharyati A, Sulisetyawati S, Oktariani M. The effectiveness of snail mucus (Achantina fulica) and chitosan towards lymphocyte proliferation in vitro. Asian J Pharm Clin Res. 2018;11(15):85-8. https://doi.org/10.22159/ajpcr.2018.v11s3.30041 DOI: https://doi.org/10.22159/ajpcr.2018.v11s3.30041

Vilchèze C, Jacobs W. Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: Genes, mutations, and causalities. Microbiol Spectr. 2014;2(4):MGM2-0014-2013. https://doi.org/10.1128/microbiolspec.mgm2-0014-2013 PMid:26104204 DOI: https://doi.org/10.1128/microbiolspec.MGM2-0014-2013

Kiepiela P, Bishop K, Smith A, Roux L, York D. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis. 2000;80(1):47-56. https://doi.org/10.1054/tuld.1999.0231 PMid:10897383 DOI: https://doi.org/10.1054/tuld.1999.0231

Burkovski A. Cell envelope of corynebacteria: Structure and influence on pathogenicity. ISRN Microbiol. 2013;2013:935736. https://doi.org/10.1155/2013/935736 PMid:23724339 DOI: https://doi.org/10.1155/2013/935736

Wu X, Yang J, Tan G, Liu H, Liu Y, Guo Y, et al. Drug resistance characteristics of Mycobacterium tuberculosis isolates from patients with tuberculosis to 12 antituberculous drugs in China. Front Cell Infect Microbiol. 2019;9:345. https://doi.org/10.3389/fcimb.2019.00345 PMid:31828045 DOI: https://doi.org/10.3389/fcimb.2019.00345